Extensive research consistently underscores the profound impact of gut health on overall well-being. Specifically, the gut microbiome assumes a pivotal role in modulating the effects of dietary choices and various environmental factors on health, encompassing functions related to digestion, immunity, metabolism, and neuroendocrine regulation. Employing appropriate diagnostic tools to evaluate gastrointestinal (GI) health can empower healthcare professionals to identify the underlying causes of chronic illnesses.

The GI-MAP (Microbial Assay Plus) sets itself apart in the realm of comprehensive stool testing. It exclusively utilizes quantitative polymerase chain reaction (qPCR) technology, enabling the detection of parasites, bacteria, fungi, and other organisms by targeting their specific DNA sequences.

Key Markers: Advanced Quantitative PCR stool Microbiome Test, Zonulin, Fecal Gluten Peptides, Digestive Markers, Intestinal Inflammation.

Sample Type: Stool

This innovative test, accompanied by a clear and easily understandable report, empowers practitioners to gain a comprehensive understanding of a patient’s overall health status. By identifying and linking disruptions in key metabolic pathways and analytes, this test facilitates the provision of personalized therapeutic interventions. Metabolomics, also known as comprehensive metabolic profiling, examines patterns of metabolites associated with fundamental biological systems, shedding light on biochemical dysfunctions that warrant attention.

Organic acids and other small molecules serve as intermediate compounds that elucidate the efficient flow of pathways and substrates, such as amino acids, unveiling the extent of inputs. Together, these factors determine the functional status of critical health areas.

Metabolites are influenced by numerous factors and can fluctuate in response to various stimuli, including diet, nutrient status, toxin exposures, physical activity, physiological demands, genetic factors, alterations in the gut microbiome, or the stage of disease.

Metabolic analysis enables clinicians to assess the functioning of key pathways more effectively, allowing for targeted support interventions.

Key Markers: Organic Acids

Sample Type: Urine